Corteva, Inc.
84.75USD
-1.1500 (-1.34%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.39▼ | $-0.28 | 2 | 12 |
| Next quarter | $0.32▲ | $0.26 | 10 | 3 |
| Current year | $3.76▲ | $3.73 | 11 | 5 |
| Next year | $3.41▲ | $3.26 | 1 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.23 | $2.3 | +0.07 (+2.9%) |
| 2026-03-31 | $1.18 | $1.5 | +0.32 (+27.1%) |
| 2025-12-31 | $0.22 | $0.22 | -0.00 (-1.6%) |
| 2025-09-30 | $-0.47 | $-0.23 | +0.24 (+50.6%) |
248 ratings from 36 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $89 $85 | Aug 18, 2026 |
| UBS | Maintained | Neutral | $86 $89 | Aug 3, 2026 |
| Citigroup | Maintained | Neutral | $85 $86 | Aug 3, 2026 |
| JP Morgan | Maintained | Neutral | $77 $83 | Aug 3, 2026 |
| BMO Capital | Maintained | Outperform | $95 $100 | Aug 3, 2026 |
| Oppenheimer | Maintained | Outperform | $89 $95 | Jul 23, 2026 |
| RBC Capital | Maintained | Outperform | $97 $103 | Jul 21, 2026 |
| B of A Securities | Maintained | Buy | $90 $96 | Jul 20, 2026 |
| Mizuho | Maintained | Outperform | $96 $97 | Jul 14, 2026 |
| Mizuho | Maintained | Outperform | $94 $96 | Jul 2, 2026 |
| Barclays | Maintained | Overweight | $84 $91 | Jun 11, 2026 |
| UBS | Maintained | Neutral | $90 $86 | Jun 9, 2026 |
| Morgan Stanley | Maintained | Overweight | $84 $95 | May 28, 2026 |
| UBS | Maintained | Neutral | $88 $90 | May 7, 2026 |
| Citigroup | Maintained | Neutral | $83 $85 | May 7, 2026 |
| RBC Capital | Maintained | Outperform | $89 $95 | Apr 24, 2026 |
| Oppenheimer | Maintained | Outperform | $86 $89 | Apr 22, 2026 |
| Wells Fargo | Maintained | Overweight | $85 $90 | Apr 21, 2026 |
| UBS | Maintained | Neutral | $80 $88 | Apr 9, 2026 |
| Argus Research | Maintained | Buy | $80 $91 | Mar 31, 2026 |
| Mizuho | Maintained | Outperform | $80 $82 | Feb 17, 2026 |
| Citigroup | Maintained | Neutral | $74 $80 | Feb 5, 2026 |
| RBC Capital | Maintained | Outperform | $80 $89 | Feb 5, 2026 |
| Wells Fargo | Maintained | Overweight | $77 $85 | Feb 5, 2026 |
| JP Morgan | Downgraded from Overweight | Neutral | $75 $77 | Feb 5, 2026 |
80 filings from 23 insiders · 0 buy / 0 sell over 6m
Officers and directors of CTVA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| POLICINSKI CHRISTOPHER JDirector | Grant | 412 | $78.71 | $33k | Jul 31, 2026 |
| GIESSELMAN JANET PLAUTDirector | Grant | 98 | $78.71 | $8k | Jul 31, 2026 |
| NAYYAR NAYAKI RDirector | Grant | 412 | $78.71 | $33k | Jul 31, 2026 |
| KISSAM LUTHER C IVChief Executive Officer | Grant | 24.1k | — | — | Jun 1, 2026 |
| GIESSELMAN JANET PLAUTDirector | Grant | 95 | $81.01 | $8k | Apr 30, 2026 |
| NAYYAR NAYAKI RDirector | Grant | 401 | $81.01 | $33k | Apr 30, 2026 |
| WARD PATRICK JDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| PREETE KERRY JDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| POLICINSKI CHRISTOPHER JDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| LUTZ MARCOS MDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| PAGE GREGORY RDirector | Grant | 3.9k | — | — | Apr 28, 2026 |
| EVERITT DAVID CDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| GIESSELMAN JANET PLAUTDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| NAYYAR NAYAKI RDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| GRIMES KAREN H.Director | Grant | 2.4k | — | — | Apr 28, 2026 |
| GILSON JEAN-MARCDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| ENGEL KLAUS ADirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| JOHNSON DAVID PAULChief Financial Officer | Grant | 24.1k | — | — | Feb 24, 2026 |
| GRIMM AUDREYOfficer | Grant | 11.3k | — | — | Feb 24, 2026 |
| O'CONNOR JUDD MOfficer | Grant | 14.2k | — | — | Feb 24, 2026 |
No analyst notes on CTVA yet.
Analyst Ratings
20 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 11 | 7 | 0 | 0 | Buy2.19 |
| 1 mo ago | 4 | 11 | 6 | 0 | 0 | Buy2.10 |
| 2 mo ago | 4 | 11 | 6 | 0 | 0 | Buy2.10 |
| 3 mo ago | 3 | 12 | 7 | 0 | 0 | Buy2.18 |